Angela A. Armstrong

Array ( [id] => 12523770 [patent_doc_number] => 10004754 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-06-26 [patent_title] => ANP fragment adjuvant therapy to standard of care (SOC) diuretic treatment [patent_app_type] => utility [patent_app_number] => 15/124804 [patent_app_country] => US [patent_app_date] => 2015-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 8 [patent_no_of_words] => 12771 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15124804 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10398228 [patent_doc_number] => 20150283236 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-10-08 [patent_title] => 'METHODS FOR TREATING SUBJECTS WITH PRIMARY HYPERCHOLESTEROLEMIA THAT IS NOT ADEQUATELY CONTROLLED' [patent_app_type] => utility [patent_app_number] => 14/657186 [patent_app_country] => US [patent_app_date] => 2015-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 17892 [patent_no_of_claims] => 61 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14657186 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11873613 [patent_doc_number] => 09745370 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-08-29 [patent_title] => 'Antibodies to sericin and methods and kits using same' [patent_app_type] => utility [patent_app_number] => 15/125780 [patent_app_country] => US [patent_app_date] => 2015-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 14944 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15125780 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10297588 [patent_doc_number] => 20150182587 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-07-02 [patent_title] => 'METHODS FOR TREATING REPERFUSION INJURIES' [patent_app_type] => utility [patent_app_number] => 14/645212 [patent_app_country] => US [patent_app_date] => 2015-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 31 [patent_no_of_words] => 10976 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14645212 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16322348 [patent_doc_number] => 10782307 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2020-09-22 [patent_title] => Use of remnant lipoprotein in the treatment and prevention of cardiovascular disease [patent_app_type] => utility [patent_app_number] => 14/639388 [patent_app_country] => US [patent_app_date] => 2015-03-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 13583 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 88 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14639388 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10387958 [patent_doc_number] => 20150272964 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-10-01 [patent_title] => 'NOVEL NON-SELECTIVE CATION CHANNEL IN NEURONAL CELLS AND METHODS FOR TREATING BRAIN SWELLING' [patent_app_type] => utility [patent_app_number] => 14/634855 [patent_app_country] => US [patent_app_date] => 2015-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 54 [patent_figures_cnt] => 54 [patent_no_of_words] => 62060 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14634855 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14258951 [patent_doc_number] => 10279019 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-05-07 [patent_title] => PCSK9 peptide vaccine conjugated to a Qbeta carrier and methods of using the same [patent_app_type] => utility [patent_app_number] => 15/118143 [patent_app_country] => US [patent_app_date] => 2015-02-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 21 [patent_no_of_words] => 17796 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15118143 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13051521 [patent_doc_number] => 10047141 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-08-14 [patent_title] => Method of manufacturing a protein by perfusion in media with a low amino acid concentration [patent_app_type] => utility [patent_app_number] => 14/609225 [patent_app_country] => US [patent_app_date] => 2015-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 10 [patent_no_of_words] => 6358 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14609225 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11944459 [patent_doc_number] => 20170248609 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-08-31 [patent_title] => 'BIOMARKERS PREDICTIVE OF MUSCLE ATROPHY, METHOD AND USE' [patent_app_type] => utility [patent_app_number] => 15/114248 [patent_app_country] => US [patent_app_date] => 2015-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 9668 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 20 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15114248 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11323869 [patent_doc_number] => 20160354480 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-12-08 [patent_title] => 'ACTIVATED NEUROTENSIN MOLECULES AND THE USES THEREOF' [patent_app_type] => utility [patent_app_number] => 15/111835 [patent_app_country] => US [patent_app_date] => 2015-01-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 16665 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15111835 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11212014 [patent_doc_number] => 09441043 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-09-13 [patent_title] => 'Methods of treating cancer with antibodies that target the insulin-like growth factor type I receptor (IGF-1R)' [patent_app_type] => utility [patent_app_number] => 14/598664 [patent_app_country] => US [patent_app_date] => 2015-01-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 30 [patent_no_of_words] => 30708 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 103 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14598664 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10483276 [patent_doc_number] => 20150368296 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-12-24 [patent_title] => 'Method for preventing or treating heart diseases by using a composition containing an isolated peptide' [patent_app_type] => utility [patent_app_number] => 14/593967 [patent_app_country] => US [patent_app_date] => 2015-01-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 4588 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14593967 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10311644 [patent_doc_number] => 20150196645 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-07-16 [patent_title] => 'Stable Aqueous Formulations of Etanercept' [patent_app_type] => utility [patent_app_number] => 14/592654 [patent_app_country] => US [patent_app_date] => 2015-01-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16539 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14592654 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10311644 [patent_doc_number] => 20150196645 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-07-16 [patent_title] => 'Stable Aqueous Formulations of Etanercept' [patent_app_type] => utility [patent_app_number] => 14/592654 [patent_app_country] => US [patent_app_date] => 2015-01-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16539 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14592654 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10298830 [patent_doc_number] => 20150183829 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-07-02 [patent_title] => 'RFAMIDE-RELATED PEPTIDES AND METHODS THEREOF' [patent_app_type] => utility [patent_app_number] => 14/582553 [patent_app_country] => US [patent_app_date] => 2014-12-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 22464 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14582553 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16446042 [patent_doc_number] => 10837965 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-11-17 [patent_title] => Methods for detecting levels of pigment epithelium-derived factor and antithrombin-III for characterising and/or prognosing prostate cancer [patent_app_type] => utility [patent_app_number] => 15/106582 [patent_app_country] => US [patent_app_date] => 2014-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 45 [patent_figures_cnt] => 45 [patent_no_of_words] => 21877 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 77 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15106582 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11393857 [patent_doc_number] => 20170014391 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-01-19 [patent_title] => 'SGK1 INHIBITORS FOR TREATMENT OF PROSTATE CANCER' [patent_app_type] => utility [patent_app_number] => 15/102236 [patent_app_country] => US [patent_app_date] => 2014-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 32 [patent_no_of_words] => 36326 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15102236 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11677158 [patent_doc_number] => 09675665 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-06-13 [patent_title] => 'Treatment of gum diseases and gum disorders with TSG-6 protein' [patent_app_type] => utility [patent_app_number] => 15/102776 [patent_app_country] => US [patent_app_date] => 2014-12-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 12 [patent_no_of_words] => 8140 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 83 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15102776 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12286213 [patent_doc_number] => 09932393 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-04-03 [patent_title] => Antibody that binds murine wise protein [patent_app_type] => utility [patent_app_number] => 14/564979 [patent_app_country] => US [patent_app_date] => 2014-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 11179 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14564979 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11108963 [patent_doc_number] => 20160305934 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-10-20 [patent_title] => 'COMPOSITIONS AND METHODS FOR IDENTIFYING AND TREATING CACHEXIA OR PRE-CACHEXIA' [patent_app_type] => utility [patent_app_number] => 15/101865 [patent_app_country] => US [patent_app_date] => 2014-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 71 [patent_figures_cnt] => 71 [patent_no_of_words] => 25412 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 34 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15101865 [rel_patent_id] =>[rel_patent_doc_number] =>)